Non-Small Cell Lung Cancer Diagnosis

A chest scan can show a suspicious area and enlarged lymph nodes, but imaging alone cannot confirm the cancer type. A biopsy removes cells or tissue for examination. It may be obtained through a bronchoscopy, a needle guided through the chest, or another procedure selected for the safest useful sample.

A pathology report may describe adenocarcinoma, squamous cell carcinoma, or another non-small cell pattern. Molecular and immune-marker testing can identify features that affect medicine choices. Staging scans assess nearby and distant areas so the team can plan treatment.

Bring previous scan images, reports, a full medicines list, allergies, and details of smoking or occupational exposures. Ask where the biopsy will be taken, how results will be shared, whether enough tissue is available for molecular testing, and when the staging discussion will happen.

Once the findings are assembled, options may include surgery such as [Lung Lobectomy](/treatments/surgical-oncology/lung-lobectomy/), focused radiation such as [Stereotactic Body Radiotherapy](/treatments/radiation-oncology/stereotactic-body-radiotherapy/), or medicines such as [Immunotherapy](/treatments/systemic-therapy/immunotherapy/) and [Targeted Therapy](/treatments/systemic-therapy/targeted-therapy/).

Get emergency help for severe breathing difficulty, blue lips, heavy coughing of blood, sudden confusion, fainting, or a new seizure. Tell the clinical team promptly about worsening breathlessness, persistent chest pain, or fever while tests are being arranged.

What did the scan show? Where will the biopsy be taken? When should I expect the pathology result? Has the sample been sent for molecular and immune-marker testing? What further scans are needed to determine the stage?